2 April 2015 - Deborah Wilkes
Archived
McNeil Consumer Healthcare is set to launch AstraZeneca's Rhinocort (budesonide) nasal spray as an OTC medicine in the US.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.